By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fate Therapeutics 

10931 North Torrey Pines Road
Suite 107
La Jolla  California  92037  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
Fate Therapeutics (FATE) to Webcast Conference Call Reporting Third Quarter 2013 Financial Results on November 13, 2013 11/7/2013 9:54:49 AM
Fate Therapeutics (FATE) to Present at World Muscle Society Congress 10/3/2013 9:49:42 AM
Fate Therapeutics (FATE) Bombs in IPO Debut, Prices at Low End of Revised Range 10/1/2013 9:31:27 AM
Orphan Disease Biotech Fate Therapeutics Files for a $69 Million IPO 8/14/2013 8:39:00 AM
Fate Therapeutics Presents Preclinical Efficacy Data for WNT7A-Analog Program at Muscular Dystrophy Association 2013 Scientific Conference 4/22/2013 1:28:56 PM
Fate Therapeutics Strengthens Leadership Position in the Development of Wnt-based Protein Therapeutics 12/4/2012 9:40:48 AM
Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies 11/27/2012 8:51:32 AM
Fate Therapeutics Names Christian Weyer New CEO 10/15/2012 7:26:34 AM
Fate Therapeutics Raises $9.2 Million for Stem Cell Treatments 8/23/2012 8:27:51 AM
Fate Therapeutics And BD Biosciences (BDX) Launch BD(TM) SMC4 to Improve Cellular Reprogramming and IPS Cell Culture Applications 6/11/2012 12:01:48 PM